Medicare Enrolled

Dr. Manuel Figueroa, M.D.

Dermatology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3800 E 1ST ST, Los Angeles, CA 90063
3232617520
In practice since 2006 (19 years)
NPI: 1770679102 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Figueroa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Figueroa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Figueroa

Dr. Manuel Figueroa is a dermatology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Figueroa performed 706 Medicare services across 292 unique beneficiaries.

Between the years covered by Open Payments, Dr. Figueroa received a total of $2,241 from 29 pharmaceutical and/or device companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Figueroa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 41% volume in CA $2,241 industry payments

Medicare Practice Summary

Medicare Utilization ↗
706
Medicare services
Top 41% in CA for dermatology
292
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~37 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
418 $61 $117
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
115 $3 $10
Virtual check-in for established patient
A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in.
40 $6 $18
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
39 $0 $10
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
25 $27 $46
Quadrivalent influenza vaccine, cell-culture derived
A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics.
21 $33 $45
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
19 $24 $25
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
17 $11 $19
Knee X-ray, 1-2 views
An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures.
12 $18 $47
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,241
Total received (2018-2024)
Avg $320/year across 7 years
Top 16% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
99
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,056 (91.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$185 (8.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$200
2023
$86
2022
$95
2021
$442
2020
$155
2019
$673
2018
$590

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$100
Novo Nordisk Inc
$30
AstraZeneca Pharmaceuticals LP
$28
Sumitomo Pharma America, Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$17
Top 3 companies account for 78.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$249
PFIZER INC.
$248
Radius Health, Inc.
$202
Bayer HealthCare Pharmaceuticals Inc.
$160
Novo Nordisk Inc
$155
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$149
BIOTRONIK INC.
$138
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
Astellas Pharma US Inc
$123
Janssen Pharmaceuticals, Inc
$83
AstraZeneca Pharmaceuticals LP
$66
Lilly USA, LLC
$56
Merck Sharp & Dohme Corporation
$53
AbbVie, Inc.
$47
Allergan, Inc.
$40
RedHill Biopharma Inc.
$34
Almatica Pharma LLC
$33
Novartis Pharmaceuticals Corporation
$33
Amarin Pharma Inc.
$32
Romark Laboratories, LC
$31
AbbVie Inc.
$28
Calliditas Therapeutics US Inc.
$27
Sumitomo Pharma America, Inc.
$26
SANOFI-AVENTIS U.S. LLC
$23
GlaxoSmithKline, LLC.
$20
Allergan Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$17
Horizon Therapeutics plc
$15
Synergy Pharmaceuticals Inc
$11
Top 3 companies account for 31.2% of all-time payments
Associated products mentioned in payments ›
ANORO · Alinia · Alinia Tablets 500mg 30 count bottle · Creon · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · GEMTESA · GRALISE · JANUVIA · Kerendia · MYRBETRIQ · PENNSAID · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · Rybelsus · TARPEYO · TOUJEO · TRULICITY · Talicia · Tresiba · Trulance · Tymlos · UBRELVY · VIBERZI · VRAYLAR · Vascepa · Victoza · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in Los Angeles?
Compare dermatologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
576
Per 100K population
5.8
County median income
$87,760
Nearest hospital
ADVENTIST HEALTH WHITE MEMORIAL
1.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Figueroa is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Figueroa experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Figueroa performed 418 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Figueroa receive payments from pharmaceutical companies?
Yes. Dr. Figueroa received a total of $2,241 from 29 companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Figueroa's costs compare to other dermatologists in Los Angeles?
Dr. Figueroa's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Figueroa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →